279 related articles for article (PubMed ID: 28714063)
1. MicroRNA-206 prevents the pathogenesis of hepatocellular carcinoma by modulating expression of met proto-oncogene and cyclin-dependent kinase 6 in mice.
Wu H; Tao J; Li X; Zhang T; Zhao L; Wang Y; Zhang L; Xiong J; Zeng Z; Zhan N; Steer CJ; Che L; Dong M; Wang X; Niu J; Li Z; Yan G; Chen X; Song G
Hepatology; 2017 Dec; 66(6):1952-1967. PubMed ID: 28714063
[TBL] [Abstract][Full Text] [Related]
2. MicroRNA-449a suppresses hepatocellular carcinoma cell growth via G1 phase arrest and the HGF/MET c-Met pathway.
Cheng J; Wu LM; Deng XS; Wu J; Lv Z; Zhao HF; Yang Z; Ni Y
Hepatobiliary Pancreat Dis Int; 2018 Aug; 17(4):336-344. PubMed ID: 30108016
[TBL] [Abstract][Full Text] [Related]
3. MicroRNA-105 suppresses cell proliferation and inhibits PI3K/AKT signaling in human hepatocellular carcinoma.
Shen G; Rong X; Zhao J; Yang X; Li H; Jiang H; Zhou Q; Ji T; Huang S; Zhang J; Jia H
Carcinogenesis; 2014 Dec; 35(12):2748-55. PubMed ID: 25280563
[TBL] [Abstract][Full Text] [Related]
4. MicroRNA-302a/d inhibits the self-renewal capability and cell cycle entry of liver cancer stem cells by targeting the E2F7/AKT axis.
Ma YS; Lv ZW; Yu F; Chang ZY; Cong XL; Zhong XM; Lu GX; Zhu J; Fu D
J Exp Clin Cancer Res; 2018 Oct; 37(1):252. PubMed ID: 30326936
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA-15a/16-1 Prevents Hepatocellular Carcinoma by Disrupting the Communication Between Kupffer Cells and Regulatory T Cells.
Liu N; Chang CW; Steer CJ; Wang XW; Song G
Gastroenterology; 2022 Feb; 162(2):575-589. PubMed ID: 34678217
[TBL] [Abstract][Full Text] [Related]
6. miR-1 suppresses the growth of esophageal squamous cell carcinoma in vivo and in vitro through the downregulation of MET, cyclin D1 and CDK4 expression.
Jiang S; Zhao C; Yang X; Li X; Pan Q; Huang H; Wen X; Shan H; Li Q; Du Y; Zhao Y
Int J Mol Med; 2016 Jul; 38(1):113-22. PubMed ID: 27247259
[TBL] [Abstract][Full Text] [Related]
7. FAK is required for c-Met/β-catenin-driven hepatocarcinogenesis.
Shang N; Arteaga M; Zaidi A; Stauffer J; Cotler SJ; Zeleznik-Le NJ; Zhang J; Qiu W
Hepatology; 2015 Jan; 61(1):214-26. PubMed ID: 25163657
[TBL] [Abstract][Full Text] [Related]
8. miR-214/199a/199a* cluster levels predict poor survival in hepatocellular carcinoma through interference with cell-cycle regulators.
Wang P; Chen S; Fang H; Wu X; Chen D; Peng L; Gao Z; Xie C
Oncotarget; 2016 Jan; 7(1):929-45. PubMed ID: 26498144
[TBL] [Abstract][Full Text] [Related]
9. Metformin delays AKT/c-Met-driven hepatocarcinogenesis by regulating signaling pathways for de novo lipogenesis and ATP generation.
Zhang C; Hu J; Sheng L; Yuan M; Wu Y; Chen L; Zheng G; Qiu Z
Toxicol Appl Pharmacol; 2019 Feb; 365():51-60. PubMed ID: 30625338
[TBL] [Abstract][Full Text] [Related]
10. AKT (v-akt murine thymoma viral oncogene homolog 1) and N-Ras (neuroblastoma ras viral oncogene homolog) coactivation in the mouse liver promotes rapid carcinogenesis by way of mTOR (mammalian target of rapamycin complex 1), FOXM1 (forkhead box M1)/SKP2, and c-Myc pathways.
Ho C; Wang C; Mattu S; Destefanis G; Ladu S; Delogu S; Armbruster J; Fan L; Lee SA; Jiang L; Dombrowski F; Evert M; Chen X; Calvisi DF
Hepatology; 2012 Mar; 55(3):833-45. PubMed ID: 21993994
[TBL] [Abstract][Full Text] [Related]
11. Dual regulatory role of CCNA2 in modulating CDK6 and MET-mediated cell-cycle pathway and EMT progression is blocked by miR-381-3p in bladder cancer.
Li J; Ying Y; Xie H; Jin K; Yan H; Wang S; Xu M; Xu X; Wang X; Yang K; Zheng X; Xie L
FASEB J; 2019 Jan; 33(1):1374-1388. PubMed ID: 30138038
[TBL] [Abstract][Full Text] [Related]
12. IGF2 Is Up-regulated by Epigenetic Mechanisms in Hepatocellular Carcinomas and Is an Actionable Oncogene Product in Experimental Models.
Martinez-Quetglas I; Pinyol R; Dauch D; Torrecilla S; Tovar V; Moeini A; Alsinet C; Portela A; Rodriguez-Carunchio L; Solé M; Lujambio A; Villanueva A; Thung S; Esteller M; Zender L; Llovet JM
Gastroenterology; 2016 Dec; 151(6):1192-1205. PubMed ID: 27614046
[TBL] [Abstract][Full Text] [Related]
13. Functional crosstalk between AKT/mTOR and Ras/MAPK pathways in hepatocarcinogenesis: implications for the treatment of human liver cancer.
Wang C; Cigliano A; Delogu S; Armbruster J; Dombrowski F; Evert M; Chen X; Calvisi DF
Cell Cycle; 2013 Jul; 12(13):1999-2010. PubMed ID: 23759595
[TBL] [Abstract][Full Text] [Related]
14. Dual inhibition of Akt and c-Met as a second-line therapy following acquired resistance to sorafenib in hepatocellular carcinoma cells.
Han P; Li H; Jiang X; Zhai B; Tan G; Zhao D; Qiao H; Liu B; Jiang H; Sun X
Mol Oncol; 2017 Mar; 11(3):320-334. PubMed ID: 28164434
[TBL] [Abstract][Full Text] [Related]
15. MiRNA-206 inhibits hepatocellular carcinoma cell proliferation and migration but promotes apoptosis by modulating cMET expression.
Wang Y; Tai Q; Zhang J; Kang J; Gao F; Zhong F; Cai L; Fang F; Gao Y
Acta Biochim Biophys Sin (Shanghai); 2019 Mar; 51(3):243-253. PubMed ID: 30805592
[TBL] [Abstract][Full Text] [Related]
16. Histone deacetylases activate hepatocyte growth factor signaling by repressing microRNA-449 in hepatocellular carcinoma cells.
Buurman R; Gürlevik E; Schäffer V; Eilers M; Sandbothe M; Kreipe H; Wilkens L; Schlegelberger B; Kühnel F; Skawran B
Gastroenterology; 2012 Sep; 143(3):811-820.e15. PubMed ID: 22641068
[TBL] [Abstract][Full Text] [Related]
17. A systematic investigation based on microRNA-mediated gene regulatory network reveals that dysregulation of microRNA-19a/Cyclin D1 axis confers an oncogenic potential and a worse prognosis in human hepatocellular carcinoma.
Zhang Y; Guo X; Li Z; Li B; Li Z; Li R; Guo Q; Xiong L; Yu L; Zhao J; Lin N
RNA Biol; 2015; 12(6):643-57. PubMed ID: 25985117
[TBL] [Abstract][Full Text] [Related]
18. SOX1 functions as a tumor suppressor by antagonizing the WNT/β-catenin signaling pathway in hepatocellular carcinoma.
Tsao CM; Yan MD; Shih YL; Yu PN; Kuo CC; Lin WC; Li HJ; Lin YW
Hepatology; 2012 Dec; 56(6):2277-87. PubMed ID: 22767186
[TBL] [Abstract][Full Text] [Related]
19. miR-1299 suppresses cell proliferation of hepatocellular carcinoma (HCC) by targeting CDK6.
Zhu H; Wang G; Zhou X; Song X; Gao H; Ma C; Chang H; Li H; Liu FF; Lu J; Ma J
Biomed Pharmacother; 2016 Oct; 83():792-797. PubMed ID: 27490780
[TBL] [Abstract][Full Text] [Related]
20. MiR-21 mediates sorafenib resistance of hepatocellular carcinoma cells by inhibiting autophagy via the PTEN/Akt pathway.
He C; Dong X; Zhai B; Jiang X; Dong D; Li B; Jiang H; Xu S; Sun X
Oncotarget; 2015 Oct; 6(30):28867-81. PubMed ID: 26311740
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
